跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BEKEMV 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BEKEMV 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
BEKEMV 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Amgen Technology (Ireland) Unlimited Company
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 27, 2023
Approval ID
710d05c0d2771133
Company
Amgen Technology (Ireland) Unlimited Company
Type
Standard
Approval Details
Approval Id
710d05c0d2771133
Drug Cima Aemps Name
BEKEMV 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1231727001
Holder Company Name
Amgen Technology (Ireland) Unlimited Company
Marketing Company Name
Amgen S.A.
Holder Company Detail Path
/organization/amgen-technology-ireland-unlimited-company
Marketing Company Detail Path
/organization/amgen-sa
Authorization Date
2023-04-27
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
300 MG
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Amgen Technology (Ireland) Unlimited Company
Company Detail Path
/organization/amgen-technology-ireland-unlimited-company
Company Information
Pharmaceutical Company Name
AMGEN TECHNOLOGY (IRELAND) UNLIMITED COMPANY
Country Name
Ireland
City Name
dun laoghaire,country_ie
Address
Pottery Road
Active Ingredients
ECULIZUMAB
300 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 27, 2023
Approval ID
710d05c0d2771133
Type
Standard
Back to CIMA-AEMPS Approvals